For more information please contact:
Head of Healthcare
Michael Margolis, R.Ph.
Warren Dunnavant II
Senior Vice President
Head of Equity
Senior Vice President
Zosano Pharma Corporation (Nasdaq: ZSAN) announced the pricing of its initial public offering of 4,500,000 shares of common stock at a price to the public of $11.00 per share. The shares began trading on the NASDAQ Capital Market under the ticker symbol "ZSAN" on January 27, 2015.
In addition, Eli Lilly and Company purchased $15 million worth of Zosano Pharma’s common stock in a separate private placement concurrent with the closing of the this offering, at a price per share equal to the initial public offering price.
ROTH Capital Partners acted as joint book-running manager for Zosano Pharma’s initial public offering and financial advisor for its private placement.
About Zosano Pharma Corporation
Zosano Pharma Corporation is a clinical stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of a variety of indications. Zosano’s microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections. Zosano’s microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies. Learn more at
www.zosanopharma.com. (Source: Company Press Release | 1/27/15)
About ROTH Capital Partners
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access. Headquartered in Newport Beach, CA, ROTH is privately-held and employee owned, and maintains offices throughout the U.S. and Hong Kong. For more information on ROTH, please visit